|
|
Volumn 1, Issue 3, 2006, Pages 223-228
|
|
Sorafenib (BAY 43-9006): review of clinical development.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
RAF PROTEIN;
SORAFENIB;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG DESIGN;
HUMAN;
NEOPLASM;
REVIEW;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
DRUG DESIGN;
DRUG THERAPY, COMBINATION;
HUMANS;
NEOPLASMS;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
RAF KINASES;
|
|
EID: 41149147579
PISSN: 15748847
EISSN: None
Source Type: Journal
DOI: 10.2174/157488406778249325 Document Type: Review |
|
Times cited : (37)
|
|
References (49)
|
